Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 1998

View Archived Issues

MK-886 demonstrates antihyperplastic activity in an animal model of intimal thickening

Alpharma acquires Hoechst's European generic pharmaceutical business

Company Profile: Integra LifeSciences

Company Profile: Sangamo BioSciences

Sepracor: Q1 1998 highlights

Transcell/Intercardia merger complete

Matritech: Q1 1998 highlights

Novartis seek patients for phase III trials of PSC-833

Phase III trials in progress for HMR antipsychotic agent

Merck KGaA, Yamanouchi to codevelop two new cardiovascular drug candidates

QLT PhotoTherapeutics updates shareholders

Evotec awarded German grant for drug discovery

EBV antigens for diagnostic use available for licensing from BioResearch Ireland

Pliva describes coumarin quinolone carboxylic acids for infections and cancer

Transcend Therapeutics announces decision to terminate Procysteine phase III trial

Novel water-soluble azoles for both oral and parenteral treatment of fungal infections

Inhibitors of IL-1beta from ADIR

Pfizer prepares new beta3-adrenoceptor agonists

New SERMs discovered at Lilly and claimed for estrogen-dependent disorders

Lilly develops assay for antitumor agent of natural origin

New light shed on the mechanisms of nicotine addiction

Introgen receives patent protection for p53 gene therapy-chemotherapeutic drug combinations

Promising new TMR data presented at scientific meeting

Novopharm Biotech withdraws IND for phase Ib trial of GPI-2A

HRT more effective than raloxifene in improving heart disease risk factors

CytoMed evaluates CMI-977 in phase I for asthma

FDA grants priority review status for Arava

Phase I clinical trial of novel analgesic to begin in Sweden

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.